These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 7985248
21. Prophylaxis and treatment of deep vein thrombosis in general surgery. Gutt CN, Oniu T, Wolkener F, Mehrabi A, Mistry S, Büchler MW. Am J Surg; 2005 Jan; 189(1):14-22. PubMed ID: 15701484 [Abstract] [Full Text] [Related]
24. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. Koch A, Bouges S, Ziegler S, Dinkel H, Daures JP, Victor N. Br J Surg; 1997 Jun; 84(6):750-9. PubMed ID: 9189079 [Abstract] [Full Text] [Related]
25. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Kamphuisen PW, Agnelli G. Thromb Res; 2007 Jun; 119(3):265-74. PubMed ID: 16674999 [Abstract] [Full Text] [Related]
27. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery. Epstein NE. Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995 [Abstract] [Full Text] [Related]
28. [Prevention of thrombosis with unfractionated and low molecular weight heparin]. Breddin HK. Wien Med Wochenschr; 1989 Dec 15; 139(23):555-9. PubMed ID: 2560285 [Abstract] [Full Text] [Related]
29. Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery. Breddin HK. Semin Thromb Hemost; 1999 Dec 15; 25 Suppl 3():83-9. PubMed ID: 10549721 [Abstract] [Full Text] [Related]
30. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin. Haas S, Wolf H, Kakkar AK, Fareed J, Encke A. Thromb Haemost; 2005 Oct 15; 94(4):814-9. PubMed ID: 16270636 [Abstract] [Full Text] [Related]
31. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis. Själander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P. J Intern Med; 2008 Jan 15; 263(1):52-60. PubMed ID: 18088252 [Abstract] [Full Text] [Related]
32. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients. Haas S. Semin Thromb Hemost; 1999 Jan 15; 25 Suppl 3():101-5. PubMed ID: 10549724 [Abstract] [Full Text] [Related]
35. [Meta-analysis on randomized trials comparing the results of low-molecular weight heparins to those of fractioned heparins in the prevention of deep venous thrombosis]. Daures JP, Schved JF, Momas I, Gril JC, Azoulay P, Gremy F. Rev Epidemiol Sante Publique; 1989 Sep 15; 37(4):363-9. PubMed ID: 2558404 [Abstract] [Full Text] [Related]
36. Differentiation of low molecular weight heparins in treatment of acute deep vein thrombosis. Davidson BL. Semin Thromb Hemost; 1999 Sep 15; 25 Suppl 3():107-12. PubMed ID: 10549725 [Abstract] [Full Text] [Related]
39. [Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery]. Grunebaum L, Fricker JP, Wiesel ML, Vergnes Y, Kapps J, Cazenave JP. J Mal Vasc; 1987 Sep 15; 12 Suppl B():102-4. PubMed ID: 2834478 [Abstract] [Full Text] [Related]